Trials of CRISPR/Cas9 are getting underway around the world. Clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9, to give it its full name, holds huge promise for tackling cancer, hereditary blindness, AIDS, cystic fibrosis, Duchenne’s muscular dystrophy, hepatitis B, Huntington’s disease and even high cholesterol...

Read more at ComputerWorld.